Print Page  Close Window

SEC Filings

OREXIGEN THERAPEUTICS, INC. filed this Form 8-K on 09/05/2018
Entire Document

Case 18-10518-KG     Doc 708     Filed 08/30/18     Page 11 of 11


In re: Orexigen Therapeutics, Inc.    Case No. 18-10518 (KG)
Debtor    Reporting Period: July 1, 2018 - July 31, 2018


Accounts Receivable Aging

As of July 31, 2018



$ USD ‘000s                                          
Accounts Receivable Aging    Current      0-30 Days      31-60 Days      61-90 Days      91 Days +      Total  

Accounts Receivable, net

   $ —        $ —        $ —        $ —        $ —        $ —    


















   $ —        $ —        $ —        $ —        $ —        $ —    

Debtor Questionnaire


Must be completed each month

   Yes      No  


   Have any assets been sold or transferred outside the normal course of business this reporting period? If yes, provide an explanation below.(1)      X     


   Have any funds been disbursed from any account other than a debtor in possession account this reporting period? If yes, provide an explanation below.         X  


   Have all post petition tax returns been timely filed? If no, provide an explanation below.      X     


   Are workers compensation, general liability and other necessary insurance coverages in effect? If no, provide an explanation below.(2)      X     


   Has any bank account been opened during the reporting period? If yes, provide documentation identifying the opened account(s). If an investment account has been opened provide the required documentation pursuant to the Delaware Local Rule 4001-3.         X  




The 363 sales transaction of substantially all Debtor assets closed on July 27, 2018. See Docket #0438 for the Order approving the sale to Nalpropion Pharmaceuticals, Inc.


The Debtor received a notice from the Workers’ Compensation Board for the State of New York regarding a failure to maintain disability and paid family leave insurance. This notice is being looked into by the Debtor, but the Debtor believes that all applicable coverages are still in effect.